Logo
![](https://icon.widen.net/content/02j83kdyf9/web/pharmafile.jpg?w=545&itok=2snyBOYl)
Thumbnail image
![](https://icon.widen.net/content/jjhx6hqkdb/web/Firecrest.jpg?w=545&itok=iVmyeWWw)
Mitigating the impact of COVID-19 on CV trials and participants
A thought leadership article authored by Jack Martin, Mary Jane Geiger and Deirdre Albertson which focuses on navigating cardiovascular clinical trials during COVID-19 by adopting patient-centric technologies to keep patients safe and studies on track. The article is published in PharmaFile Spring 2020 on page 40.